X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PLETHICO PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PLETHICO PHARMA J.B.CHEMICALS/
PLETHICO PHARMA
 
P/E (TTM) x 17.3 -1.1 - View Chart
P/BV x 2.2 0.0 13,049.8% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 J.B.CHEMICALS   PLETHICO PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
PLETHICO PHARMA
Mar-14
J.B.CHEMICALS/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs363395 91.9%   
Low Rs25531 814.7%   
Sales per share (Unadj.) Rs169.1604.4 28.0%  
Earnings per share (Unadj.) Rs16.632.5 51.1%  
Cash flow per share (Unadj.) Rs23.451.3 45.6%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.5473.6 36.4%  
Shares outstanding (eoy) m83.5734.08 245.2%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.80.4 518.2%   
Avg P/E ratio x18.66.6 283.8%  
P/CF ratio (eoy) x13.24.2 317.9%  
Price / Book Value ratio x1.80.5 398.1%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,8277,262 355.6%   
No. of employees `0003.8NA-   
Total wages/salary Rs m2,5111,596 157.3%   
Avg. sales/employee Rs Th3,747.4NM-  
Avg. wages/employee Rs Th665.7NM-  
Avg. net profit/employee Rs Th367.8NM-  
INCOME DATA
Net Sales Rs m14,13520,598 68.6%  
Other income Rs m366386 94.7%   
Total revenues Rs m14,50120,984 69.1%   
Gross profit Rs m2,1782,818 77.3%  
Depreciation Rs m570642 88.7%   
Interest Rs m351,593 2.2%   
Profit before tax Rs m1,940969 200.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m552-138 -399.1%   
Profit after tax Rs m1,3871,107 125.3%  
Gross profit margin %15.413.7 112.7%  
Effective tax rate %28.5-14.3 -199.3%   
Net profit margin %9.85.4 182.6%  
BALANCE SHEET DATA
Current assets Rs m10,47018,877 55.5%   
Current liabilities Rs m2,74911,896 23.1%   
Net working cap to sales %54.633.9 161.2%  
Current ratio x3.81.6 240.0%  
Inventory Days Days5536 153.6%  
Debtors Days Days78198 39.3%  
Net fixed assets Rs m5,8119,861 58.9%   
Share capital Rs m167341 49.0%   
"Free" reserves Rs m14,24812,331 115.6%   
Net worth Rs m14,41616,139 89.3%   
Long term debt Rs m04,706 0.0%   
Total assets Rs m17,64933,146 53.2%  
Interest coverage x56.61.6 3,518.5%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.80.6 128.9%   
Return on assets %8.18.1 98.9%  
Return on equity %9.66.9 140.3%  
Return on capital %13.712.3 111.4%  
Exports to sales %021.4 0.0%   
Imports to sales %015.2 0.0%   
Exports (fob) Rs mNA4,402 0.0%   
Imports (cif) Rs mNA3,136 0.0%   
Fx inflow Rs m6,1644,402 140.0%   
Fx outflow Rs m1,3343,184 41.9%   
Net fx Rs m4,8291,219 396.3%   
CASH FLOW
From Operations Rs m1,2312,437 50.5%  
From Investments Rs m-208-6,265 3.3%  
From Financial Activity Rs m-5952,490 -23.9%  
Net Cashflow Rs m427-1,337 -31.9%  

Share Holding

Indian Promoters % 55.4 82.7 67.0%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 4.3 78.8%  
FIIs % 3.9 5.5 70.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 7.5 493.3%  
Shareholders   30,437 10,665 285.4%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DR. DATSONS LABS  BIOCON   FULFORD INDIA  NATCO PHARMA  DIVIS LABORATORIES  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Positive Note for Third Straight Day; Yes Bank Falls 5%(Closing)

Indian share markets traded on a positive note most of the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the IT sector.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

A One Stock Crorepati(Profit Hunter)

Jul 4, 2019

Do you wish you could become a crorepati in the stock market? Read on...

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jul 17, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS